Paper24100711
The potential of the human immune system to develop broadly neutralizing HIV-1 antibodies: implications for vaccine development.
Zhang Y and 7 others. AIDS, 2013. Cited by 10 papers, by iCite.
Cite this record
ConductScience Library. The potential of the human immune system to develop broadly neutralizing HIV-1 antibodies: implications for vaccine development. Papers, record 24100711. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/24100711
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- The potential of the human immune system to develop broadly neutralizing HIV-1 antibodies: implications for vaccine development.
- PubMed
Topics10
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| AIDS Vaccines | Major topic |
| Antibodies, Neutralizing | Major topic |
| HIV Antibodies | Major topic |
| HIV-1 | Major topic |
| Gene Library | |
| HIV Infections | |
| Healthy Volunteers | |
| High-Throughput Nucleotide Sequencing | |
| Humans | |
| Leukocytes, Mononuclear |
Source PubMed
References36
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 19100741 | A method for identification of HIV gp140 binding memory B cells in human blood. | J Immunol Methods | 2009 | https://conductscience.org/library/papers/19100741 | PubMed |
| 2 | 21998254 | A potent and broad neutralizing antibody recognizes and penetrates the HIV glycan shield. | Science | 2011 | https://conductscience.org/library/papers/21998254 | PubMed |
| 3 | 21835983 | Focused evolution of HIV-1 neutralizing antibodies revealed by structures and deep sequencing. | Science | 2011 | https://conductscience.org/library/papers/21835983 | PubMed |
| 4 | 20538861 | Crystal structure of PG16 and chimeric dissection with somatically related PG9: structure-function analysis of two quaternary-specific antibodies that effectively neutralize HIV-1. | J Virol | 2010 | https://conductscience.org/library/papers/20538861 | PubMed |
| 5 | 17369702 | B cell superantigens subvert innate functions of B cells. | Chem Immunol Allergy | 2007 | https://conductscience.org/library/papers/17369702 | PubMed |
| 6 | 11498595 | Crystal structure of a neutralizing human IGG against HIV-1: a template for vaccine design. | Science | 2001 | https://conductscience.org/library/papers/11498595 | PubMed |
| 7 | 20098712 | Analysis of memory B cell responses and isolation of novel monoclonal antibodies with neutralizing breadth from HIV-1-infected individuals. | PLoS One | 2010 | https://conductscience.org/library/papers/20098712 | PubMed |
| 8 | 20616231 | Structural basis for broad and potent neutralization of HIV-1 by antibody VRC01. | Science | 2010 | https://conductscience.org/library/papers/20616231 | PubMed |
| 9 | 21849977 | Broad neutralization coverage of HIV by multiple highly potent antibodies. | Nature | 2011 | https://conductscience.org/library/papers/21849977 | PubMed |
| 10 | 6095449 | Molecular characterization of human T-cell leukemia (lymphotropic) virus type III in the acquired immune deficiency syndrome. | Science | 1984 | https://conductscience.org/library/papers/6095449 | PubMed |
| 11 | 20616233 | Rational design of envelope identifies broadly neutralizing human monoclonal antibodies to HIV-1. | Science | 2010 | https://conductscience.org/library/papers/20616233 | PubMed |
| 12 | 16174734 | Dissection of the carbohydrate specificity of the broadly neutralizing anti-HIV-1 antibody 2G12. | Proc Natl Acad Sci U S A | 2005 | https://conductscience.org/library/papers/16174734 | PubMed |
| 13 | 7973652 | Efficient neutralization of primary isolates of HIV-1 by a recombinant human monoclonal antibody. | Science | 1994 | https://conductscience.org/library/papers/7973652 | PubMed |
| 14 | 22301150 | Two distinct broadly neutralizing antibody specificities of different clonal lineages in a single HIV-1-infected donor: implications for vaccine design. | J Virol | 2012 | https://conductscience.org/library/papers/22301150 | PubMed |
| 15 | 10644369 | Oligomeric modeling and electrostatic analysis of the gp120 envelope glycoprotein of human immunodeficiency virus. | J Virol | 2000 | https://conductscience.org/library/papers/10644369 | PubMed |
| 16 | 12478295 | HIV-1 evades antibody-mediated neutralization through conformational masking of receptor-binding sites. | Nature | 2002 | https://conductscience.org/library/papers/12478295 | PubMed |
| 17 | 22903666 | Nature and nurture of catalytic antibodies. | Adv Exp Med Biol | 2012 | https://conductscience.org/library/papers/22903666 | PubMed |
| 18 | 11788027 | A potent cross-clade neutralizing human monoclonal antibody against a novel epitope on gp41 of human immunodeficiency virus type 1. | AIDS Res Hum Retroviruses | 2001 | https://conductscience.org/library/papers/11788027 | PubMed |
| 19 | 19748484 | Germline-like predecessors of broadly neutralizing antibodies lack measurable binding to HIV-1 envelope glycoproteins: implications for evasion of immune responses and design of vaccine immunogens. | Biochem Biophys Res Commun | 2009 | https://conductscience.org/library/papers/19748484 | PubMed |
| 20 | 11997472 | Broadly cross-reactive HIV-1-neutralizing human monoclonal Fab selected for binding to gp120-CD4-CCR5 complexes. | Proc Natl Acad Sci U S A | 2002 | https://conductscience.org/library/papers/11997472 | PubMed |
Cited by5
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 10 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 31906351 | Exploiting B Cell Receptor Analyses to Inform on HIV-1 Vaccination Strategies. | Vaccines (Basel) | 2020 | https://conductscience.org/library/papers/31906351 | PubMed |
| 30013279 | SIV-Specific Antibodies are Elicited by a Recombinant Fowlpox Virus Co-expressing SIV Gag and envT. | Indian J Microbiol | 2018 | https://conductscience.org/library/papers/30013279 | PubMed |
| 29632541 | 5' Rapid Amplification of cDNA Ends and Illumina MiSeq Reveals B Cell Receptor Features in Healthy Adults, Adults With Chronic HIV-1 Infection, Cord Blood, and Humanized Mice. | Front Immunol | 2018 | https://conductscience.org/library/papers/29632541 | PubMed |
| 26844022 | Short-term assessment of BCR repertoires of SLE patients after high dose glucocorticoid therapy with high-throughput sequencing. | Springerplus | 2016 | https://conductscience.org/library/papers/26844022 | PubMed |
| 24998424 | Deep sequencing: becoming a critical tool in clinical virology. | J Clin Virol | 2014 | https://conductscience.org/library/papers/24998424 | PubMed |
Genes21
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/24100711
GET https://conductscience.org/api/papers/v1/24100711/references?page=2